Skip to main content

The Wistar Institute

|

The Wistar Institute Welcomes Michele A. Schiavoni, New Vice President of Communications & Marketing

PHILADELPHIA—(September 8, 2022)—The Wistar Institute is pleased to announce the appointment of Michele A. Schiavoni, M.S., as Vice President of Communications & Marketing, in a central leadership role that will bolster the visibility of the I…
Read more
|

The Wistar Institute and Jubilant Therapeutics Inc. Find PAD4 Inhibition in Neutrophils Halts Cancer Progression and Metastasis

PHILADELPHIA — (Sept. 7, 2022) — Researchers in the laboratory of Yulia Nefedova, M.D., Ph.D., at The Wistar Institute and collaborators at Jubilant Therapeutics Inc. have uncovered a novel mechanism by which protein arginine deiminase 4 (PAD4) in…
Read more
|

Advancing Scientific Enterprise at Wistar’s Vaccine and Immunotherapy Center

With just over a year at The Wistar Institute under their respective scientific belts, innovator-scientists Amelia Escolano, Ph.D., and Daniel Claiborne, Ph.D., have been pushing the scientific envelope in Wistar laboratories using mouse models to…
Read more
|

Scientists Drive Innovation at Wistar’s Ellen and Ronald Caplan Cancer Center

Wistar continues to be a dynamic environment prepared to tackle biomedical challenges in a collaborative, innovative, and inclusive culture. Read more about our Ellen and Ronald Caplan Cancer Center commitment to scientific career development, a d…
Read more
|

A Wistar Journey Through the Past, Present, and Future of Immunization Work

Vaccines are a crucial public health tool in its’ arsenal against diseases. Resurgences of diseases long thought eradicated are popping up decades later in sewage waters here and abroad, and we’ve witnessed what the impact of war has on countries …
Read more
|

[Hybrid] Distinguished Lectures in Cancer Research Series: GCDH and NR2F6 in Melanoma Addiction and Immune Evasion

Scientific Seminar Tuesday, Sept. 13, 2022 12:00 p.m. to 1:00 p.m. The Distinguished Lectures in Cancer Research series is the flagship seminar series of the Ellen and Ronald Caplan Cancer Center and features national and international leaders in …
Read more
|

Distinguished Lectures in Cancer Research Series: Germline TP53 Variants and Cancer – Lessons Learned from Li-Fraumeni Syndrome

Scientific Seminar Tuesday, Oct. 25, 2022 12:00 p.m. to 1:00 p.m. The Distinguished Lectures in Cancer Research series is the flagship seminar series of the Ellen and Ronald Caplan Cancer Center and features national and international leaders in b…
Read more
|

Distinguished Lectures in Cancer Research Series: PARPs and ADP-ribosylation in Gene Regulation and Cancer

Scientific Seminar Tuesday, Sept. 20, 2022 12:00 p.m. to 1:00 p.m. The Distinguished Lectures in Cancer Research series is the flagship seminar series of the Ellen and Ronald Caplan Cancer Center and features national and international leaders in …
Read more
|

Virtual Cores Day 2022

Special Event Thursday, Sept. 15, 2022 10:00 a.m. to 2:00 p.m. Join this free virtual event and get to know the nearly 100 research core facilities representing Wistar, CHOP and UPenn. The annual Cores Day event is a joint venture with CHOP, PSOM …
Read more
|

Looking Inside the Gut for Answers to Long-COVID

This Q&A offers a behind the science peek into some of the long-term effects of COVID on the body influenced by the gut microbiome. In a paper published in JCI Insight, Mohamed Abdel-Mohsen, Ph.D., associate professor in The Wistar Institute V…
Read more